A drug developed by Roche extended the lives of patients with an aggressive form of breast cancer by longer than ever before, the company said, as patents on a key oncology drug approach expiry.
from WSJ.com: US Business http://ift.tt/1nq9yDH
via IFTTT
from WSJ.com: US Business http://ift.tt/1nq9yDH
via IFTTT
No comments:
Post a Comment